Evidence map›Paper›PMID 31913135›Full record

ArticleJMIR research protocols2020

Factors Associated With Trial Completion and Adherence in App-Based N-of-1 Trials: Protocol for a Randomized Trial Evaluating Study Duration, Notification Level, and Meaningful Engagement in the Brain Boost Study.

Jason R Bobe, Jacqueline Buros, Eddye Golden, Matthew Johnson, Michael Jones, Bethany Percha, Ryan Viglizzo, Noah Zimmerman

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04056650 (Data Driven Health Decisions in the Wild), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04056650 phase4terminatednot on this map

Data Driven Health Decisions in the Wild: A Platform for Actionable N-of-1 Studies

TypeinterventionalSponsorIcahn School of Medicine at Mount SinaiRan2019 to 2020Enrolled57ConditionsCognitive PerformanceArmsL-theanine, Caffeine supplement, N1 app
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jason R BobeInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0003-1864-8609
Jacqueline BurosInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0001-9588-4889
Eddye GoldenInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0002-9818-5693
Matthew JohnsonInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0001-7056-2824
Michael JonesInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0002-6305-3893
Bethany PerchaInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0003-0988-4183
Ryan ViglizzoInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0002-7699-2646
Noah ZimmermanInstitute for Next Generation Healthcare, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID https://orcid.org/0000-0003-3391-2623
Icahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundN-of-1 trials promise to help individuals make more informed decisions about treatment selection through structured experiments that compare treatment effectiveness by alternating treatments and measuring their impacts in a single individual. We created a digital platform that automates the design, administration, and analysis of N-of-1 trials. Our first N-of-1 trial, the app-based Brain Boost Study, invited individuals to compare the impacts of two commonly consumed substances (caffeine and L-theanine) on their cognitive performance.

objectiveThe purpose of this study is to evaluate critical factors that may impact the completion of N-of-1 trials to inform the design of future app-based N-of-1 trials. We will measure study completion rates for participants that begin the Brain Boost Study and assess their associations with study duration (5, 15, or 27 days) and notification level (light or moderate).

methodsParticipants will be randomized into three study durations and two notification levels. To sufficiently power the study, a minimum of 640 individuals must begin the study, and 97 individuals must complete the study. We will use a multiple logistic regression model to discern whether the study length and notification level are associated with the rate of study completion. For each group, we will also compare participant adherence and the proportion of trials that yield statistically meaningful results.

resultsWe completed the beta testing of the N1 app on a convenience sample of users. The Brain Boost Study on the N1 app opened enrollment to the public in October 2019. More than 30 participants enrolled in the first month.

conclusionsTo our knowledge, this will be the first study to rigorously evaluate critical factors associated with study completion in the context of app-based N-of-1 trials.

trial registrationClinicalTrials.gov NCT04056650; https://clinicaltrials.gov/ct2/show/NCT04056650. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/16362.

Indexed as

adherenceattritioncognitioncrossover trialsmHealthmobile appsmotivationN-of-1 trialsnootropicsrandomized controlled trialstudy durationusability

Identifiers

PMID31913135
PMCPMC6996754
OpenAlexW2992272861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.